Efficacy of SL-701 in adult patients with glioblastoma multiforme.

Trial Profile

Efficacy of SL-701 in adult patients with glioblastoma multiforme.

Completed
Phase of Trial: Phase II

Latest Information Update: 26 Apr 2018

At a glance

  • Drugs SL 701 (Primary)
  • Indications Glioblastoma
  • Focus Therapeutic Use
  • Most Recent Events

    • 26 Apr 2018 According to a Stemline Therapeutics media release, data from this trial will be presented at the 54th Annual Meeting of the American Society of Clinical Oncology (ASCO) (Jun 2018).
    • 08 Mar 2018 Status changed from active, no longer recruiting to completed, according to a Stemline Therapeutics media release.
    • 10 May 2017 According to a Stemline Therapeutics media release, updates from this trial are expected in 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top